This inventor holds 1 USPTO granted patent. Top assignee: Shionogi & Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ayumi Nagasawa: Innovator in Nucleic Acid Drug Development
Introduction
Ayumi Nagasawa is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of drug development, particularly in the area of nucleic acid therapies. Her innovative work has garnered attention in the scientific community.
Latest Patents
Ayumi holds a patent for a groundbreaking invention titled "Nucleic Acid Drug Targeting MuRF1." This patent represents her commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Ayumi Nagasawa is currently employed at Shionogi & Co., Ltd., a leading pharmaceutical company known for its dedication to research and development. Her role at Shionogi has allowed her to work on cutting-edge projects that aim to address critical health challenges.
Collaborations
Throughout her career, Ayumi has collaborated with esteemed colleagues, including Takahiro Fujiwara and Kazuyoshi Tomita. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Ayumi Nagasawa is a trailblazer in the field of nucleic acid drug development, with a notable patent and a strong career at Shionogi & Co., Ltd. Her contributions continue to shape the future of medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile